Get more info

Get more information
on LUCENTIS:
1-866-LUCENTIS
(1-866-582-3684)

Monday-Friday
8AM-9PM (EST)

 

You'll receive helpful tips & tools, a free information kit, and much more.

Sign Up Now
   


In 2 clinical studies, patients were given LUCENTIS® (ranibizumab injection) on 2 different treatment schedules. Patients were given LUCENTIS monthly in 1 study. In another study, patients were given 4 monthly LUCENTIS injections and then received injections once every 3 months. Treating with LUCENTIS monthly gives you the best chance to improve your vision. Patients that received LUCENTIS monthly for only 4 months saw a gradual loss in their vision (approximately 5 letters or 1 line) over the following 9 months.

Because everyone is different, your retina specialist will regularly monitor your vision and determine the right treatment schedule for you.

It is recommended that you have a friend or family member come with you to each retina specialist visit. This is because your eye will have been dilated before your injection. Injections were generally well tolerated in key clinical studies. In fact, nearly 95% of patients returned to continue treatment.








Who is LUCENTIS for?


LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (AMD).


Important LUCENTIS Safety Information


Like any prescription medication, LUCENTIS is not for everyone. You should not use LUCENTIS if you have an infection in or around the eye.


Like other injections given into the eye, serious eye infection (endophthalmitis) and detached retina have occurred with LUCENTIS. Increases in eye pressure have been seen within 1 hour of an injection. Your eye doctor should monitor your eye pressure and eye health during the week after the injection. If your eye becomes red, sensitive to light, painful, or has a change in vision, you should seek immediate care from your eye doctor.


Although uncommon, conditions associated with eye- and non–eye-related blood clots (arterial thromboembolic events) may occur.


Serious side effects related to the injection procedure were rare. These included serious eye infection, detached retina, and cataract. Other uncommon serious side effects included inflammation inside the eye and increased eye pressure.


The most common eye-related side effects were red eye, eye pain, small specks in vision, the feeling that something is in your eye, and increased tears. The most common non–eye-related side effects were high blood pressure, nose and throat infection, and headache.


LUCENTIS is for prescription use only.

Individual results with LUCENTIS may vary.


Please see LUCENTIS full Prescribing Information.